Drug Information

Drug General Information
Drug ID
D0SX7F
Former ID
DNC013055
Drug Name
AZALANSTAT
Drug Type
Small molecular drug
Indication Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] Discontinued in Phase 2 [545151]
Formula
C22H24ClN3O2S
Canonical SMILES
C1C(OC(O1)(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)CSC4=CC=C(C=C4)<br />N
InChI
1S/C22H24ClN3O2S/c23-18-3-1-17(2-4-18)9-10-22(15-26-12-11-25-16-26)27-13-20(28-22)14-29-21-7-5-19(24)6-8-21/h1-8,11-12,16,20H,9-10,13-15,24H2/t20-,22-/m0/s1
InChIKey
VYNIUBZKEWJOJP-UNMCSNQZSA-N
CAS Number
CAS 143484-82-6
PubChem Compound ID
60876
Target and Pathway
Target(s) Fungal Cytochrome P450 51 Target Info Modulator
References
Ref 545151Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002302)

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.